NASDAQ:TENX
Tenax Therapeutics, Inc.
- Stock
Last Close
6.92
06/11 21:00
Market Cap
6.52M
Beta: 2.17
Volume Today
20.29K
Avg: 3.72M
PE Ratio
−20.44
PFCF: −0.36
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 200.98K - | |||||||||
average payables | 691.81K - | 850.04K 22.87% | 669.73K 21.21% | 680.84K 1.66% | 1.21M 77.05% | 1.21M 0.33% | 808.75K 33.13% | 654.03K 19.13% | 1.26M 92.77% | |
average receivables | 57.78K - | 61.02K 5.62% | 61.38K 0.59% | 25.09K 59.13% | ||||||
book value per share | 860.81 - | 243.83 71.67% | 125.93 48.35% | 150.46 19.48% | 12.18 91.91% | 8.92 26.72% | 4.13 53.77% | 1.01 75.41% | 32.59 3,112.68% | |
capex per share | -1.56 - | -0.04 97.37% | -0.06 56.80% | -0.10 50.91% | -0.01 88.11% | -0.01 41.64% | -0.01 24.19% | -0.00 69.07% | 0.01 824.76% | |
capex to depreciation | -0.74 - | -0.15 79.44% | -0.33 118.89% | -0.84 152.90% | -0.03 96.05% | -0.03 8.71% | -0.05 58.45% | -0.02 57.47% | 0.38 1,932.25% | |
capex to operating cash flow | 0.01 - | 0.00 98.38% | 0.00 105.66% | 0.00 269.55% | 0.00 65.75% | 0.00 20.43% | 0.00 28.54% | 0.00 60.03% | -0.00 349.04% | |
capex to revenue | -2.22 - | |||||||||
cash per share | 287.62 - | 188.92 34.32% | 109.56 42.01% | 164.40 50.05% | 17.43 89.40% | 12.95 25.70% | 5.43 58.10% | 1.44 73.40% | 39.41 2,630.59% | |
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 366.20 - | |||||||||
debt to assets | 0.00 - | 0.03 - | 0.04 64.60% | 0.05 9.27% | 0.24 388.99% | |||||
debt to equity | 0.00 - | 0.05 - | 0.07 44.87% | 0.07 3.88% | 0.54 690.03% | |||||
dividend yield | 3.87 - | |||||||||
earnings yield | -0.15 - | -0.80 423.88% | -0.64 20.17% | -3.56 456.18% | -0.96 72.98% | -0.51 46.72% | -1.53 198.73% | -3.38 121.06% | 1.41 141.78% | |
enterprise value | 88.53M - | 44.84M 49.36% | 12.22M 72.75% | -10.47M 185.72% | 4.00M 138.20% | 13.34M 233.27% | 16.11M 20.79% | 1.95M 87.89% | -4.33M 322.19% | |
enterprise value over ebitda | -6.49 - | -2.32 64.35% | -1.33 42.58% | 1.52 214.45% | -0.47 131.13% | -1.37 189.21% | -0.50 63.67% | -0.18 64.14% | -0.56 214.96% | |
ev to operating cash flow | -9.08 - | -2.83 68.89% | -1.01 64.37% | 1.90 289.23% | -0.53 127.80% | -1.44 171.57% | -1.48 3.17% | -0.16 89.06% | 0.73 552.12% | |
ev to sales | 1.80K - | |||||||||
free cash flow per share | -140.45 - | -225.81 60.78% | -172.19 23.74% | -70.39 59.12% | -24.40 65.33% | -17.90 26.66% | -10.56 41.02% | -8.17 22.64% | -23.75 190.83% | |
free cash flow yield | -0.11 - | -0.29 170.44% | -0.88 203.47% | -2.91 231.07% | -0.87 70.25% | -0.48 44.40% | -0.51 5.49% | -3.68 624.78% | -1.08 70.61% | |
graham net net | 109.16 - | 101.51 7.01% | 95.79 5.63% | 144.38 50.73% | 9.06 93.72% | 8.62 4.83% | 3.73 56.76% | 0.14 96.14% | 24.98 17,258.14% | |
graham number | 1.97K - | 1.85K 6.07% | 595.91 67.81% | 539.78 9.42% | 86.17 84.04% | 61.84 28.23% | 54.34 12.13% | 13.09 75.91% | 150.87 1,052.57% | |
income quality | 0.69 - | 0.36 47.81% | 1.37 280.09% | 0.39 71.69% | 0.90 131.51% | 0.94 4.57% | 0.33 64.48% | 1.09 225.26% | 0.77 29.59% | |
intangibles to total assets | 0.46 - | 0 100% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -301.88 - | -1.62 99.46% | -6.07K - | -34.49K 468.61% | -2.49K 92.79% | 321.72 112.93% | ||||
interest debt per share | 2.13 - | 462.32 21,644.58% | 0.55 - | 0.59 6.73% | 0.28 52.08% | 0.55 94.72% | 0.10 82.53% | |||
inventory turnover | ||||||||||
invested capital | 0.00 - | 0.05 - | 0.07 44.87% | 0.07 3.88% | 0.54 690.03% | |||||
market cap | 92.09M - | 54.83M 40.46% | 13.82M 74.79% | 1.89M 86.30% | 8.74M 361.38% | 19.28M 120.71% | 21.40M 11.00% | 3.27M 84.74% | 5.46M 67.11% | |
net current asset value | 8.00M - | 7.43M 7.10% | 7.05M 5.05% | 11.75M 66.64% | 3.59M 69.48% | 4.55M 26.88% | 3.94M 13.42% | 1.30M 67.11% | 8.10M 524.53% | |
net debt to ebitda | 0.26 - | 0.52 97.65% | 0.17 66.18% | 1.80 929.01% | 0.56 68.81% | 0.61 8.98% | 0.16 73.22% | 0.12 26.39% | -1.27 1,154.93% | |
net income per share | -200.61 - | -624.82 211.45% | -125.33 79.94% | -86.07 31.33% | -27.10 68.51% | -19.05 29.72% | -31.81 67.03% | -7.51 76.41% | 31.04 513.49% | |
operating cash flow per share | -138.88 - | -225.77 62.56% | -172.13 23.76% | -70.29 59.16% | -24.39 65.30% | -17.89 26.65% | -10.55 41.02% | -8.16 22.62% | -23.76 191.03% | |
payables turnover | ||||||||||
receivables turnover | 1.00 - | |||||||||
research and ddevelopement to revenue | 135.14 - | |||||||||
return on tangible assets | -0.35 - | -1.88 430.85% | -0.89 52.51% | -0.50 43.51% | -1.32 161.21% | -1.44 8.97% | -5.46 280.07% | -3.24 40.62% | 0.66 120.35% | |
revenue per share | 0.70 - | |||||||||
roe | -0.23 - | -2.56 999.54% | -1.00 61.16% | -0.57 42.52% | -2.23 288.99% | -2.13 4.09% | -7.71 261.33% | -7.40 4.06% | 0.95 112.87% | |
roic | -0.25 - | -2.60 943.57% | -0.99 61.79% | -0.58 41.75% | -2.08 259.16% | -1.98 4.69% | -6.83 244.99% | -4.45 34.93% | 0.95 121.41% | |
sales general and administrative to revenue | 145.49 - | |||||||||
shareholders equity per share | 860.81 - | 243.83 71.67% | 125.93 48.35% | 150.46 19.48% | 12.18 91.91% | 8.92 26.72% | 4.13 53.77% | 1.01 75.41% | 32.59 3,112.68% | |
stock based compensation to revenue | 2.38 - | |||||||||
tangible asset value | 27.16M - | 17.14M 36.88% | 8.88M 48.18% | 11.77M 32.53% | 3.77M 67.95% | 4.63M 22.61% | 4.24M 8.23% | 1.49M 64.83% | 8.10M 442.50% | |
tangible book value per share | 386.90 - | 243.83 36.98% | 125.93 48.35% | 150.46 19.48% | 12.18 91.91% | 8.92 26.72% | 4.13 53.77% | 1.01 75.41% | 32.59 3,112.68% | |
working capital | 15.96M - | 7.43M 53.45% | 7.05M 5.05% | 11.75M 66.64% | 3.65M 68.96% | 4.68M 28.18% | 4.13M 11.79% | 1.36M 67.01% | 8.10M 495.06% |
All numbers in USD (except ratios and percentages)